Based on data from the past 90 days ending December 12, 2025, Atea Pharmaceuticals's three largest insider shareholders are Director Franklin M Berger (506.50K shares), Director Bruno Lucidi (112.75K shares), Director Bruce Polsky (95.21K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jean-Pierre Sommadossi | President And CEO And And Chairman | 6,166,965 | 04 Feb, 2025 |
| Andrea Corcoran | 717,307 | 04 Feb, 2025 | |
| Franklin M Berger | 506,497 | 24 Jun, 2025 | |
| Bruno Lucidi | 112,750 | 24 Jun, 2025 | |
| Bruce Polsky | 95,206 | 24 Jun, 2025 | |
| Polly A. Murphy | 86,045 | 24 Jun, 2025 | |
| Janet Mj Hammond | Chief Development Officer | 81,388 | 04 Feb, 2025 |
| Jerome M. Adams | 62,750 | 24 Jun, 2025 | |
| Barbara Gayle Duncan | 62,750 | 24 Jun, 2025 | |
| Maria Arantxa Horga | Chief Medical Officer | 60,876 | 04 Feb, 2025 |
| John Vavricka | Chief Commercial Officer | 52,081 | 04 Feb, 2025 |
| Wayne Foster | EVP And Chief Accounting Officer | 50,128 | 04 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jun, 2025 | Bruno Lucidi | Common Stock | A | 29,600 | $0.00 | 112,750 | D | M |
| 20 Jun, 2025 | Polly A. Murphy | Common Stock | A | 29,600 | $0.00 | 86,045 | D | M |
| 20 Jun, 2025 | Franklin M Berger | Common Stock | A | 29,600 | $0.00 | 506,497 | D | M |
| 20 Jun, 2025 | Bruce Polsky | Common Stock | A | 29,600 | $0.00 | 95,206 | D | M |
| 20 Jun, 2025 | Barbara Gayle Duncan | Common Stock | A | 29,600 | $0.00 | 62,750 | D | M |
| 20 Jun, 2025 | Jerome M. Adams | Common Stock | A | 29,600 | $0.00 | 62,750 | D | M |
| 31 Jan, 2025 | Maria Arantxa Horga | Common Stock | A | 41,533 | - | 67,197 | D | M |
| 31 Jan, 2025 | Maria Arantxa Horga | - | - | 67,197 | D | |||
| 31 Jan, 2025 | Andrea Corcoran | Common Stock | A | 44,367 | - | 722,909 | D | M |
| 31 Jan, 2025 | Wayne Foster | Common Stock | A | 33,333 | - | 54,190 | D | M |
| 31 Jan, 2025 | Jean-Pierre Sommadossi | Common Stock | A | 173,467 | - | 290,024 | D | M |
| 31 Jan, 2025 | Janet Mj Hammond | Common Stock | A | 46,800 | - | 84,272 | D | M |
| 31 Jan, 2025 | John Vavricka | Common Stock | A | 33,333 | - | 54,848 | D | M |
| 31 Jan, 2025 | Janet Mj Hammond | Common Stock | A | 11,250 | - | 95,522 | D | A |
| 31 Jan, 2025 | John Vavricka | Common Stock | A | 8,750 | - | 63,598 | D | A |
| 31 Jan, 2025 | Andrea Corcoran | Common Stock | A | 10,500 | - | 733,409 | D | A |
| 31 Jan, 2025 | Maria Arantxa Horga | Common Stock | A | 9,750 | - | 76,947 | D | A |
| 31 Jan, 2025 | Wayne Foster | Common Stock | A | 8,000 | - | 62,190 | D | A |
| 31 Jan, 2025 | Jean-Pierre Sommadossi | Common Stock | A | 99,517 | - | 389,541 | D | A |
| 31 Jan, 2025 | Maria Arantxa Horga | - | - | 76,947 | D |